Project measures / variables set:   Graham1   CD4_brain

ID, description, units MPD:63329   CD4_brain   percentage of CD3+ T cells that are CD4+ in brain, post infection   [%]  
West Nile virus study
Measures
• day 7    • day 12    • day 21    • day 28
Data set, strains Graham1   CC RIX   5 strains     sex: m     age: 8-10wks
Procedure immune cell quantification
Comparisontimecourse but different cohorts
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES

Cannot connect to database






  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 3 502.5694 167.5231 1.2389 0.3175
strain 2 162.3445 81.1722 0.6003 0.5567
group:strain 6 3408.0115 568.0019 4.2007 0.005
Residuals 24 3245.1987 135.2166

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Graham1 63329 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD4+ in brain, post infection   [%]   day 7  CD4_brain_d7 CC RIX 5 m 8-10wks
Graham1 63330 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD4+ in brain, post infection   [%]   day 12  CD4_brain_d12 CC RIX 5 m 8-10wks
Graham1 63331 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD4+ in brain, post infection   [%]   day 21  CD4_brain_d21 CC RIX 4 m 8-10wks
Graham1 63332 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD4+ in brain, post infection   [%]   day 28  CD4_brain_d28 CC RIX 5 m 8-10wks